Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19 | Open Heart

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

This article has a correction. Please see:

Correction: Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19 - October 01, 2020

XML

Editorial

Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19

Online download statistics by month:

Online download statistics by month: September 2020 to July 2022

	Abstract	Full	Pdf
Sep 2020	2278	2260	1064
Oct 2020	1018	994	226
Nov 2020	993	976	157
Dec 2020	3314	3122	655
Jan 2021	2664	2473	466
Feb 2021	847	787	242
Mar 2021	908	829	271
Apr 2021	860	806	259
May 2021	844	802	221
Jun 2021	1180	1159	181
Jul 2021	1537	1485	191
Aug 2021	3500	3268	427
Sep 2021	3143	2743	596
Oct 2021	1621	1406	1471
Nov 2021	1116	1032	268
Dec 2021	1575	1505	269
Jan 2022	1925	1849	343
Feb 2022	1090	1059	167
Mar 2022	673	653	125
Apr 2022	515	512	157
May 2022	546	532	75
Jun 2022	434	426	65
Jul 2022	574	567	61
Total	33155	31245	7957